Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds

被引:135
|
作者
Apelqvist, Jan [2 ,6 ]
Armstrong, David G. [1 ]
Lavery, Lawrence A. [3 ]
Boulton, Andrew J. M. [4 ,5 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Scholls Ctr Lower Extrem Ambulatory Res, Chicago, IL 60064 USA
[2] Lund Univ, Div Clin Sci, Lund, Sweden
[3] Texas A&M Univ, Dept Surg, Scott & White Hosp, Hlth Sci Ctr,Coll Med, Temple, TX USA
[4] Univ Miami, Miami, FL USA
[5] Manchester Royal Infirm, Univ Dept Med, Manchester M13 9WL, Lancs, England
[6] Malmo Univ Hosp, Dept Endocrinol, Malmo, Sweden
关键词
amputation; wound; ulcer; infection; resource utilization; diabetes;
D O I
10.1016/j.amjsurg.2007.06.023
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: To evaluate resource utilization and direct economic costs of care for patients treated with negative-pressure wound therapy (NPWT), using the Vacuum-Assisted Closure (V.A.C.) system, compared to standard moist wound therapy (MWT). METHODS: A total of 162 diabetic patients with post-amputation wounds (up to the trans-metatarsal level) entered a 16-week, randomized clinical trial. Patients randomized to V.A.C. (n = 77) received therapy with dressing changes every 48 hours. Control patients (n = 85) received standard MWT. Resource utilization, procedures, and direct costs were calculated and analyzed in this post hoc retrospective study. RESULTS: There was no difference between groups for in-patient hospital stay (number of admissions or length of stay). More surgical procedures (including debridement) were required in the MWT group (120 vs 43 NPWT, P < .001). The average number of dressing changes performed per patient was 118.0 (range 12-226) for MWT versus 41 (6-140) for NPWT (P = .0001). The MWT group had 11 (range 0-106) outpatient treatment visits during the study versus 4 (range 0-47) in the NPWT group (P < .05). The average direct cost per patient treated for 8 weeks or longer (independent of clinical outcome) was $27,270 and $36,096 in the NPWT and MWT groups, respectively. The average total cost to achieve healing was $25,954 for patients treated with NPWT (n = 43) compared with $38,806 for the MWT group (n = 33). CONCLUSION: Treatment of diabetic patients with post amputation wounds using NPWT resulted in lower resource utilization and a greater proportion of patients obtaining wound healing at a lower overall cost of care when compared to MWT. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:782 / 788
页数:7
相关论文
共 24 条
  • [21] Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
    Travis A Motley
    Adrienne M Gilligan
    Darrell L Lange
    Curtis R Waycaster
    Jaime E Dickerson
    Journal of Foot and Ankle Research, 8
  • [22] Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
    Motley, Travis A.
    Gilligan, Adrienne M.
    Lange, Darrell L.
    Waycaster, Curtis R.
    Dickerson, Jaime E., Jr.
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2015, 8
  • [23] Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgery
    Hackshaw, Michelle D.
    Krishna, Arun
    Mauro, David J.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 169 - 176
  • [24] A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study
    Frykberg, Robert G.
    Franks, Peter J.
    Edmonds, Michael
    Brantley, Jonathan N.
    Teot, Luc
    Wild, Thomas
    Garoufalis, Matthew G.
    Lee, Aliza M.
    Thompson, Janette A.
    Reach, Gerard
    Dove, Cyaandi R.
    Lachgar, Karim
    Grotemeyer, Dirk
    Renton, Sophie C.
    DIABETES CARE, 2020, 43 (03) : 616 - 624